SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?


To: David Howe who wrote (1672)7/1/2003 12:42:32 AM
From: Miljenko Zuanic  Respond to of 3044
 
I am talking about drug future value, as market potential and drug economic (profit). EU and Japan oncology market together are larger than US, but due to lower penetration into market and lower (combined) drug price drug economic is lower. This will change in coming years, imo. Drug price in US will decline, due to competition and smaller bucks available, while due to economic prospect in rest of the world drug treatment will be priced accordingly.

Miljenko